Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Henry N. Ginsberg et al.|European Heart Journal|2017Cited by 3.8k
2016 ESC/EAS Guidelines for the Management of DyslipidaemiasAlberico L. Catapano, José Luis Zamorano, Ian Graham et al.|European Heart Journal|2016Cited by 3.2k
2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Alexandros Protonotarios et al.|European Heart Journal|2023Cited by 2.3k
2023 ESC Guidelines for the management of endocarditisVictoria Delgado, Ulf Landmesser, Nina Ajmone Marsan et al.|European Heart Journal|2023Cited by 1.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, Stephen J. Nicholls et al.|European Heart Journal|2020Cited by 1.5k